Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has ...

The gross proceeds from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by Outlook Therapeutics are expected to be approximately $13.0 million.

We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at ...

Advanced Micro Devices (NASDAQ: AMD) is an important player in the global semiconductor industry as its chips power multiple ...

AMD stock is down nearly 50%, but explosive growth in AI, gaming, and data centers could make it one of 2025's biggest ...

AMD gains CPU market share from Intel, and ZT Systems acquisition strengthens its data center competitiveness against Nvidia.

Nvidia Corporation's strong AI demand, growth prospects, & customer expansion signal a bright future. Click for NVDA ...

Stocks are being undercut by trade tensions and concerns about the fiscal outlook.  Comments today from President Trump knocked Apple’s shares down more than -2% and weighed on technology stocks when ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...